Marc Lipsitch
Center for Communicable Disease Dynamics and Department of Epidemiology
Harvard School of Public Health
Boston
MA 02115
USA
Name/email consistency: high
- Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Lipsitch, M., Abdullahi, O., DʼAmour, A., Xie, W., Weinberger, D.M., Tchetgen Tchetgen, E., Scott, J.A. Epidemiology (2012)
- Negative controls: a tool for detecting confounding and bias in observational studies. Lipsitch, M., Tchetgen Tchetgen, E., Cohen, T. Epidemiology (2010)
- Influenza seasonality: lifting the fog. Lipsitch, M., Viboud, C. Proc. Natl. Acad. Sci. U.S.A. (2009)
- How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lipsitch, M., Hayden, F.G., Cowling, B.J., Leung, G.M. Lancet (2009)
- Antiviral resistance and the control of pandemic influenza. Lipsitch, M., Cohen, T., Murray, M., Levin, B.R. PLoS Med. (2007)
- Patterns of antigenic diversity and the mechanisms that maintain them. Lipsitch, M., O'Hagan, J.J. J. R. Soc. Interface (2007)
- Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine. Lipsitch, M., O'Neill, K., Cordy, D., Bugalter, B., Trzcinski, K., Thompson, C.M., Goldstein, R., Pelton, S., Huot, H., Bouchet, V., Reid, R., Santosham, M., O'Brien, K.L. J. Infect. Dis. (2007)
- Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?. Lipsitch, M., Whitney, C.G., Zell, E., Kaijalainen, T., Dagan, R., Malley, R. PLoS Med. (2005)
- Invited commentary: real-time tracking of control measures for emerging infections. Lipsitch, M., Bergstrom, C.T. Am. J. Epidemiol. (2004)
- Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures. Lipsitch, M., Bergstrom, C.T., Antia, R. BMC Med. Genet. (2003)
- Antibiotics in agriculture: when is it time to close the barn door?. Lipsitch, M., Singer, R.S., Levin, B.R. Proc. Natl. Acad. Sci. U.S.A. (2002)
- Potential benefits of a serodiagnostic test for herpes simplex virus type 1 (HSV-1) to prevent neonatal HSV-1 infection. Lipsitch, M., Davis, G., Corey, L. Sex. Transm. Dis (2002)
- Historical intensity of natural selection for resistance to tuberculosis. Lipsitch, M., Sousa, A.O. Genetics (2002)
- Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Lipsitch, M. Clin. Infect. Dis. (2001)
- Microbiology. Bacterial population genetics and disease. Lipsitch, M. Science (2001)
- The rise and fall of antimicrobial resistance. Lipsitch, M. Trends Microbiol. (2001)
- Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Lipsitch, M., Dykes, J.K., Johnson, S.E., Ades, E.W., King, J., Briles, D.E., Carlone, G.M. Vaccine (2000)
- Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models. Lipsitch, M., Bacon, T.H., Leary, J.J., Antia, R., Levin, B.R. Antimicrob. Agents Chemother. (2000)